AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers
- 18 August 2011
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 19 (4) , 411-417
Abstract
In liver cirrhosis, abnormal liver architecture impairs efficient transduction of hepatocytes with large viral vectors such as adenoviruses. Here we evaluated the ability of adeno-associated virus (AAV) vectors, small viral vectors, to transduce normal and cirrhotic rat livers. Using AAV serotype-1 (AAV1) encoding luciferase (AAV1Luc) we analyzed luciferase expression with a CCD camera. AAV1Luc was injected through the hepatic artery (intra-arterial (IA)), the portal vein (intra-portal (IP)), directly into the liver (intra-hepatic (IH)) or infused into the biliary tree (intra-biliar). We found that AAV1Luc allows long-term and constant luciferase expression in rat livers. Interestingly, IP administration leads to higher expression levels in healthy than in cirrhotic livers, whereas the opposite occurs when using IA injection. IH administration leads to similar transgene expression in cirrhotic and healthy rats, whereas intra-biliar infusion is the least effective route. After 70% partial hepatectomy, luciferase expression decreased in the regenerating liver, suggesting lack of efficient integration of AAV1 DNA into the host genome. AAV1Luc transduced mainly the liver but also the testes and spleen. Within the liver, transgene expression was found mainly in hepatocytes. Using a liver-specific promoter, transgene expression was detected in hepatocytes but not in other organs. Our results indicate that AAVs are convenient vectors for the treatment of liver cirrhosis.Keywords
This publication has 34 references indexed in Scilit:
- Combinatorial gene therapy renders increased survival in cirrhotic ratsJournal of Biomedical Science, 2010
- Hepatocyte nuclear factor 4α attenuates hepatic fibrosis in ratsGut, 2009
- Dual Therapeutic Effects of Interferon-α Gene Therapy in a Rat Hepatocellular Carcinoma Model With Liver CirrhosisMolecular Therapy, 2008
- Superoxide dismutase gene transfer reduces portal pressure in CCl 4 cirrhotic rats with portal hypertensionGut, 2008
- Adenovirus‐mediated inhibition of SPARC attenuates liver fibrosis in ratsThe Journal of Gene Medicine, 2008
- Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in ratsGut, 2007
- Liver transduction with a simian virus 40 vector encoding insulin-like growth factor I reduces hepatic damage and the development of liver cirrhosisGene Therapy, 2006
- Adeno-associated virus mediated interferon-gamma inhibits the progression of hepatic fibrosis in vitro andin vivoWorld Journal of Gastroenterology, 2005
- Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implicationsNature Clinical Practice Gastroenterology & Hepatology, 2004
- Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversionGene Therapy, 2002